Indian Pharmaceuticals & Biotech Stable Growth Stocks

Rubicon Research

Market Cap: ₹282.9b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Emcure Pharmaceuticals

Market Cap: ₹350.3b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Ajanta Pharma

Market Cap: ₹444.1b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Neuland Laboratories

Market Cap: ₹294.5b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹271.3b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Granules India

Market Cap: ₹209.5b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

Lupin

Market Cap: ₹994.5b

Operates as a pharmaceutical company in India, the United States, and internationally.

Ipca Laboratories

Market Cap: ₹489.3b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India.

Aurobindo Pharma

Market Cap: ₹930.8b

A pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally.

Aether Industries

Market Cap: ₹216.8b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Sai Life Sciences

Market Cap: ₹308.7b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Abbott India

Market Cap: ₹561.7b

Operates as a pharmaceutical company in India.

Anthem Biosciences

Market Cap: ₹492.6b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹504.8b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Biocon

Market Cap: ₹675.7b

Manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally.